Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WST11-mediated photodynamic therapy in non-resectable cholangiocarcinoma
2009-011897-14Phase 2Active
- Sponsor
- Steba Biotech
- Start
- May 2009
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of padeliporfin VTP in cholangiocarcinoma (CCA), sponsored by Steba Biotech. Started May 2009; status: active.
02
Drugs
padeliporfin VTP
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on 2009-011897-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011897-14.